{"date":"2025-05-29","count":35,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6576-2025-05-29-1909-1asmasq","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"19:09:04","subject":"本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-05-29 19:09，「本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-05-29-1833-n4k13f","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-05-29","time":"18:33:47","subject":"公告本公司董事會通過辦理現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-05-29 18:33，「公告本公司董事會通過辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-05-29-1716-1m0hkem","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-29","time":"17:16:13","subject":"公告本公司MPB-1734抗癌藥物新劑型新藥第1期臨床研究數據分析結果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-05-29 17:16，「公告本公司MPB-1734抗癌藥物新劑型新藥第1期臨床研究數據分析結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-29-1710-wr0tu2","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"17:10:20","subject":"公告本公司總經理異動","clause":"第6款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-29 17:10，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2025-05-29-1645-k9tiq9","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-29","time":"16:45:15","subject":"代重要子公司康儀科技股份有限公司公告除息基準日","clause":"第31款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2025-05-29 16:45，「代重要子公司康儀科技股份有限公司公告除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2025-05-29-1644-jyqeqq","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-29","time":"16:44:59","subject":"公告本公司董事長訂定除息基準日及調整配息率","clause":"第31款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2025-05-29 16:44，「公告本公司董事長訂定除息基準日及調整配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2025-05-29-1644-17fccth","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-29","time":"16:44:38","subject":"本公司114年股東常會通過解除董事及其代表人競業禁止之限制案","clause":"第22款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2025-05-29 16:44，「本公司114年股東常會通過解除董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2025-05-29-1644-ds864w","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-29","time":"16:44:12","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2025-05-29 16:44，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-05-29-1623-ds864w","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"16:23:53","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-05-29 16:23，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-05-29-1623-1firfk4","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"16:23:36","subject":"代重要子公司百林物流股份有限公司公告113年度盈餘分配案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-05-29 16:23，「代重要子公司百林物流股份有限公司公告113年度盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-05-29-1623-bgdg7f","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"16:23:12","subject":"代重要子公司常春藤生技股份有限公司公告113年度盈餘分配案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-05-29 16:23，「代重要子公司常春藤生技股份有限公司公告113年度盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-29-1623-1av1fn9","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"16:23:09","subject":"公告本公司董事會委任第六屆薪資報酬委員","clause":"第6款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-29 16:23，「公告本公司董事會委任第六屆薪資報酬委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-05-29-1623-146ltly","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-05-29","time":"16:23:01","subject":"公告本公司114年4月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-05-29 16:23，「公告本公司114年4月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2025-05-29-1618-ds864w","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"16:18:50","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2025-05-29 16:18，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-05-29-1614-1863nbk","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-05-29","time":"16:14:12","subject":"公告本公司民國114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-05-29 16:14，「公告本公司民國114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-29-1534-1n5rhr7","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"15:34:24","subject":"公告本公司選任董事長","clause":"第6款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-29 15:34，「公告本公司選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-29-1533-1n6zo0d","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"15:33:20","subject":"公告本公司董事會決議除息基準日相關事宜","clause":"第14款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-29 15:33，「公告本公司董事會決議除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-05-29-1513-1h6ggz3","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"15:13:19","subject":"本公司第4屆薪資報酬委員會委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-05-29 15:13，「本公司第4屆薪資報酬委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-05-29-1512-l5pp6q","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"15:12:39","subject":"本公司第4屆審計委員會委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-05-29 15:12，「本公司第4屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-05-29-1510-pmh2je","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"15:10:26","subject":"公告本公司股東會決議通過解除董事之競業禁止","clause":"第21款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-05-29 15:10，「公告本公司股東會決議通過解除董事之競業禁止」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-05-29-1510-1gajc8e","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"15:10:26","subject":"本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-05-29 15:10，「本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-05-29-1509-4f7th1","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"15:09:47","subject":"本公司新任法人董事指派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-05-29 15:09，「本公司新任法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-05-29-1509-d9bwy4","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"15:09:45","subject":"公告本公司114年度股東常會重要決議事項","clause":"第18款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-05-29 15:09，「公告本公司114年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-05-29-1506-zbp7jr","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"15:06:04","subject":"本公司股東會通過解除新任董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-05-29 15:06，「本公司股東會通過解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-05-29-1504-1ob8scv","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"15:04:21","subject":"114年股東常會全面改選董事之當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-05-29 15:04，「114年股東常會全面改選董事之當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-05-29-1502-441vkr","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"15:02:50","subject":"公告本公司股票初次上市前現金增資發行新股承銷價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-05-29 15:02，「公告本公司股票初次上市前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-05-29-1502-tf43ka","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-05-29","time":"15:02:18","subject":"本公司114年股東會重大決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-05-29 15:02，「本公司114年股東會重大決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-05-29-1501-13du5im","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"15:01:07","subject":"本公司股東會重要決議日期誤植更正公告","clause":"第18款","fact_date":"2025-05-28","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-05-29 15:01，「本公司股東會重要決議日期誤植更正公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-05-29-1451-9j8d8o","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"14:51:19","subject":"本公司拋棄式膀胱鏡通過歐盟醫療器材法規MDR審查","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-05-29 14:51，「本公司拋棄式膀胱鏡通過歐盟醫療器材法規MDR審查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-05-29-1436-5wy6x","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"14:36:52","subject":"公告本公司董事會通過委任第六屆薪資報酬委員會委員。","clause":"第6款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-05-29 14:36，「公告本公司董事會通過委任第六屆薪資報酬委員會委員。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-05-29-1436-14pdud3","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"14:36:39","subject":"公告本公司董事長及副董事長選任。","clause":"第6款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-05-29 14:36，「公告本公司董事長及副董事長選任。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-05-29-1436-4akmfd","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"14:36:26","subject":"公告本公司審計委員會委員任期屆滿異動。","clause":"第6款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-05-29 14:36，「公告本公司審計委員會委員任期屆滿異動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-05-29-1436-ndzi8h","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"14:36:12","subject":"公告本公司股東常會決議解除董事及其代表人競業禁止之限制。","clause":"第21款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-05-29 14:36，「公告本公司股東常會決議解除董事及其代表人競業禁止之限制。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-05-29-1435-16nx8kd","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"14:35:58","subject":"公告本公司114年股東常會改選董事(含獨立董事)當選名單。","clause":"第6款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-05-29 14:35，「公告本公司114年股東常會改選董事(含獨立董事)當選名單。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-05-29-1435-jnf97a","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-05-29","time":"14:35:42","subject":"公告本公司114年股東常會重要決議事項。","clause":"第18款","fact_date":"2025-05-29","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-05-29 14:35，「公告本公司114年股東常會重要決議事項。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}